Although features such as beta-amyloid or tau may be used to illustrate the progression of the hallmark neuropathology relating to Alzheimer's disease, additional combinations of neural features captured through EEG and structural MRI may provide further insight on the neurodegeneration and neuronal injury (including synaptic dysfunction) that occurs with disease progression. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.